- 61–66. doi:10.1002/syn.890030109. PMID 2521959. S2CID 23503235.
Waeber C,
Schoeffter P,
Palacios JM,
Hoyer D (June 1988). "Molecular
pharmacology of 5-HT1D...
- 61–66. doi:10.1002/syn.890030109. PMID 2521959. S2CID 23503235.
Waeber C,
Schoeffter P,
Palacios JM,
Hoyer D (June 1988). "Molecular
pharmacology of 5-HT1D...
- doi:10.1016/s0014-2999(97)00131-3. PMID 9163561.
Neijt HC,
Karpf A,
Schoeffter P,
Engel G,
Hoyer D (May 1988). "Characterisation of 5-HT3 recognition...
- PMID 9513592. Mahé C,
Loetscher E,
Feuerbach D, Müller W,
Seiler MP,
Schoeffter P (July 2004). "Differential
inverse agonist efficacies of SB-258719,...
-
testing models. Mahé C,
Loetscher E,
Feuerbach D, Müller W,
Seiler MP,
Schoeffter P (July 2004). "Differential
inverse agonist efficacies of SB-258719,...
- and
growth hormone secretion. 8-OH-DPAT
Befiradol Buspirone Eptapirone Schoeffter P,
Hoyer D (November 1988). "Centrally
acting hypotensive agents with...
-
Substituted piperazine Diphenylpiperazine Phenylpiperazine Quipazine Schoeffter P,
Hoyer D (June 1989). "Interaction of
arylpiperazines with 5-HT1A, 5-HT1B...
-
drugs such as cocaine.
Nozulak J,
Kalkman HO,
Floersheim P,
Hoyer D,
Schoeffter P,
Buerki HR (January 1995). "(+)-cis-4,5,7a,8,9,10,11...
- doi:10.1097/00005344-198111000-00018. PMID 6173531. S2CID 53762649.
Schoeffter P,
Hoyer D (November 1988). "Centrally
acting hypotensive agents with...
-
animal studies. Mahé C,
Loetscher E,
Feuerbach D, Müller W,
Seiler MP,
Schoeffter P (July 2004). "Differential
inverse agonist efficacies of SB-258719,...
